Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
NCT07275489

CHOICE KERGUELEN 2 : Consequences of Longterm Confinement on Immunity in the Sub-Antarctic Islands : Follow-up of Volunteers on the Kerguelen Islands

Led by University Hospital, Angers · Updated on 2025-12-30

9

Participants Needed

1

Research Sites

53 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Angers

Lead Sponsor

I

Institut Polaire Français Paul Emile Victor

Collaborating Sponsor

AI-Summary

What this Trial Is About

Living for long periods in extreme environments-like Antarctic research stations or space missions-can have a significant impact on human health, especially on the immune system. Scientists have observed that people in such isolated conditions often experience more infections and a reactivation of viruses that usually stay dormant in the body, such as Herpes viruses. These changes affect both parts of the immune system: the rapid-response "innate" system and the slower, more specific "adaptive" system. These immune disruptions may be caused by multiple stressors: ongoing psychological stress, disturbed sleep and light cycles (circadian rhythm disruption), and the challenges of living in confined, isolated, and extreme environments. While space missions and Antarctic overwintering programs have provided some insight into these issues, scientists still lack a detailed understanding of how the immune system adapts-or fails to adapt-over time in such conditions. To help fill this gap, the CHOICE Kerguelen 2 study will follow a group of healthy young adults who will spend one year (from November 2025 to November 2026) in Port-aux-Français, a remote French research station on the Kerguelen Islands in the sub-Antarctic. These volunteers are participating in a civic service program and will be living in a highly isolated environment for the duration of their mission. The CHOICE Kerguelen study is conducted in collaboration with the French Polar Institute (IPEV). The goal of the study is to collect and store a broad range of biological samples-including blood, saliva, stool, urine, and hair-from these volunteers at four time points during the time of their confinement on the Kerguelent Islands: tevery three months during their stay. These samples will be than analyzed to characterize the immune profiles and intestinal microbiota of the subjects assess eventual viral reactivations and stress biological markers. These analyses will allow to better understand how the immune system reacts to prolonged isolation, and to identify immune profiles that may develop under prolonged stress and limited social contact. The long-term aim of this project is not only to improve our understanding of human immunity in extreme environments, but also to inform medical research for people living with chronic illness. By studying healthy individuals placed in physically and mentally challenging environments, scientists can better understand how stress and isolation may weaken immune defenses. The findings may one day help design new approaches to support immune health in vulnerable populations.

CONDITIONS

Official Title

CHOICE KERGUELEN 2 : Consequences of Longterm Confinement on Immunity in the Sub-Antarctic Islands : Follow-up of Volunteers on the Kerguelen Islands

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy people aged over 18 years
  • Participant affiliated with or benefiting from a social security system
  • Participant has signed informed consent
  • Participant staying as an overwintering member at Kerguelen from November 2025 to November 2026
  • Participant included in the CELREMED research project of the University Hospital of Angers on healthy volunteers in the context of CHOICE Kerguelen 1 protocol
Not Eligible

You will not qualify if you...

  • Age under 18 years
  • Pregnant, breastfeeding, or postpartum women
  • Immunocompromised people (primary immunodeficiency, HIV infection, or immunosuppressive treatment)
  • Person refusing to participate in the study
  • Person with a history of autoimmune disease
  • Person deprived of liberty by judicial or administrative decision
  • Person undergoing involuntary psychiatric treatment
  • Person subject to a legal protection measure

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hôpital SAMUKER, Port-aux-français/ Archipel KERGUELEN /Terres Australes et Antarctiques Françaises

Port-aux-Français, Terres Australes Et Antarctiques Françaises, French Southern and Antarctic Lands

Actively Recruiting

Loading map...

Research Team

C

Charline MIOT, MD

CONTACT

A

Anthéa LOIEZ

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here